Ms. Griffin is well versed in the area of preterm labour. As Director of International Product Development with Ferring Pharmaceuticals in Europe, Patricia completed the development of 2 novel obstetrics products. More recently in her 20-year career, she was Vice President, Business Development at GlycoDesign Inc., a Canadian biotech company (since acquired by Inflazyme) where she established and managed international strategic alliances for the company's cancer, cardiovascular and inflammation programs. Patricia also founded Griffin Biopharma Consulting and has provided consulting services in business development and drug development to pharmaceutical and biotech companies as well as universities.

Ms. Kalina's 17 years with GSK included positions as Head of Marketing and Director of New Products and Licensing. She has developed an extensive international network and assisted over 30 pharmaceutical and biotech companies with over 60 Canadian and International agreements. She also spent 3 years as President and Board of Director member of the successful start-up biotech company YM BioSciences Inc. She has served on the board of four publicly traded Canadian biotech companies. Most recently,Diane was Principal Consultant and President BioCatalyst Yorkton Ltd., a licensing and partnerships consultancy.

Dr Götz graduated in Chemical Engineering from Vienna University of Technology and subsequently became certified as a Project Management Professional (PMP®). He has spent more than 9 years with in the pharmaceutical industry mainly in process validation and project leadership in product development and process implementation. Most recently he held the position of Global Project Manager Vaccines with Baxter BioScience. He also has specialized training in European Patent Law and spent two years preparing patent and trademark applications for the patent attorneys of Kopecky & Schwarz of Vienna.